{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:19:00Z","timestamp":1779333540056,"version":"3.51.4"},"reference-count":47,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2022,11,24]]},"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To perform a network meta-analysis of randomised controlled trials of different surfactant treatment strategies for respiratory distress syndrome (RDS) to assess if a certain fraction of inspired oxygen (FiO<jats:sub>2<\/jats:sub>) is optimal for selective surfactant therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Systematic review and network meta-analysis using Bayesian analysis of randomised trials of prophylactic versus selective surfactant for RDS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Cochrane Central Register of Controlled Trials, MEDLINE, Embase and Science Citation Index Expanded.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients<\/jats:title>\n                  <jats:p>Randomised trials including infants under 32 weeks of gestational age.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Interventions<\/jats:title>\n                  <jats:p>Intratracheal surfactant, irrespective of type or dose.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measures<\/jats:title>\n                  <jats:p>Our primary outcome was neonatal mortality, compared between groups treated with selective surfactant therapy at different thresholds of FiO<jats:sub>2<\/jats:sub>. Secondary outcomes included respiratory morbidity and major complications of prematurity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 4643 identified references, 14 studies involving 5298 participants were included. We found no statistically significant differences between 30%, 40% and 50% FiO<jats:sub>2<\/jats:sub> thresholds. A sensitivity analysis of infants treated in the era of high antenatal steroid use and nasal continuous positive airway pressure as initial mode of respiratory support showed no difference in mortality, RDS or intraventricular haemorrhage alone but suggested an increase in the combined outcome of major morbidities in the 60% threshold.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our results do not show a clear benefit of surfactant treatment at any threshold of FiO<jats:sub>2<\/jats:sub>. The 60% threshold was suggestive of increased morbidity. There was no advantage seen with prophylactic treatment. Randomised trials of different thresholds for surfactant delivery are urgently needed to guide clinicians and provide robust evidence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PROSPERO registration number<\/jats:title>\n                  <jats:p>CRD42020166620.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/archdischild-2022-324184","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T13:20:28Z","timestamp":1670592028000},"page":"333-341","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Thresholds for surfactant use in preterm neonates: a network meta-analysis"],"prefix":"10.1136","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5220-5372","authenticated-orcid":false,"given":"Aoife","family":"Branagan","sequence":"first","affiliation":[{"name":"Paediatric and Newborn Medicine, Coombe Women and Infants University Hospital, Dublin, Ireland"},{"name":"Division of Surgery and Interventional Science, UCL, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Yu","sequence":"additional","affiliation":[{"name":"Paediatric and Newborn Medicine, Coombe Women and Infants University Hospital, Dublin, Ireland"},{"name":"Division of Surgery and Interventional Science, UCL, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurinchi","family":"Gurusamy","sequence":"additional","affiliation":[{"name":"Division of Surgery and Interventional Science, UCL, London, UK"},{"name":"Department of Therapy, I.M. Sechenov First Moscow State Medical University, Moskva, Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0489-6054","authenticated-orcid":false,"given":"Jan","family":"Miletin","sequence":"additional","affiliation":[{"name":"Paediatric and Newborn Medicine, Coombe Women and Infants University Hospital, Dublin, Ireland"},{"name":"UCD School of Medicine, University College Dublin, Dublin, Ireland"},{"name":"Institute for the Care of Mother and Child, Prague, Czech Republic"},{"name":"2nd Faculty of Medicine, Motol University Hospital, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"key":"2025090511531573000_108.4.333.1","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.13500"},{"key":"2025090511531573000_108.4.333.2","doi-asserted-by":"publisher","DOI":"10.1159\/000499361"},{"key":"2025090511531573000_108.4.333.3","first-page":"Cd000510","article-title":"Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants","volume":"2","author":"Soll","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090511531573000_108.4.333.4","first-page":"Cd000510","article-title":"Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants","volume":"3","author":"Rojas-Reyes","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090511531573000_108.4.333.5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1055\/s-0036-1582395","article-title":"Surfactant treatment threshold during nCPAP for the treatment of preterm infants with respiratory distress syndrome","volume":"33","author":"Dani","year":"2016","journal-title":"Am J Perinatol"},{"key":"2025090511531573000_108.4.333.6","doi-asserted-by":"publisher","DOI":"10.1159\/000346460"},{"key":"2025090511531573000_108.4.333.7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-3443"},{"key":"2025090511531573000_108.4.333.8","unstructured":"Excellence NIfHaC . Specialist neonatal respiratory care for babies born preterm. NICE guideline [NG124], 2019."},{"key":"2025090511531573000_108.4.333.9","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/pxaa116"},{"key":"2025090511531573000_108.4.333.10","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199912000-00007"},{"key":"2025090511531573000_108.4.333.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(78)80282-0"},{"key":"2025090511531573000_108.4.333.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(05)80189-5"},{"key":"2025090511531573000_108.4.333.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-3955(05)70413-2"},{"key":"2025090511531573000_108.4.333.14","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.7.991"},{"key":"2025090511531573000_108.4.333.15","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200108000-00006"},{"key":"2025090511531573000_108.4.333.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"2025090511531573000_108.4.333.17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.2517-6161.1993.tb01921.x","article-title":"Bayesian interval estimates which are also confidence intervals","volume":"55","author":"Severini","year":"1993","journal-title":"J R Stat Soc"},{"key":"2025090511531573000_108.4.333.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.03.016"},{"key":"2025090511531573000_108.4.333.19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076654"},{"key":"2025090511531573000_108.4.333.20","doi-asserted-by":"publisher","DOI":"10.1001\/2012.jama.11228"},{"key":"2025090511531573000_108.4.333.21","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X12458724"},{"key":"2025090511531573000_108.4.333.22","first-page":"47","article-title":"Use of surfactant for prophylaxis versus rescue treatment of respiratory distress syndrome: experience from an Italian-Bulgarian trial","volume":"68 Suppl 1","author":"Bevilacqua","year":"1997","journal-title":"Acta Biomed Ateneo Parmense"},{"key":"2025090511531573000_108.4.333.23","first-page":"2018","article-title":"[Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants]","volume":"136","author":"de Winter","year":"1992","journal-title":"Ned Tijdschr Geneeskd"},{"key":"2025090511531573000_108.4.333.24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/14767058.2013.818120","article-title":"Early regular versus late selective poractant treatment in preterm infants born between 25 and 30 gestational weeks: a prospective randomized multicenter study","volume":"27","author":"Dilmen","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025090511531573000_108.4.333.25","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-3848"},{"key":"2025090511531573000_108.4.333.26","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1542\/peds.92.6.768","article-title":"Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial","volume":"92","author":"Egberts","year":"1993","journal-title":"Pediatrics"},{"key":"2025090511531573000_108.4.333.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0911783"},{"key":"2025090511531573000_108.4.333.28","doi-asserted-by":"publisher","DOI":"10.1159\/000345198"},{"key":"2025090511531573000_108.4.333.29","first-page":"90","article-title":"Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation","volume":"92","author":"Kattwinkel","year":"1993","journal-title":"Pediatrics"},{"key":"2025090511531573000_108.4.333.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199103283241301"},{"key":"2025090511531573000_108.4.333.31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/jmf.14.3.187.196","article-title":"Clinical course of premature infants intubated in the delivery room, submitted or not to porcine-derived lung surfactant therapy within the first hour of life","volume":"14","author":"Lefort","year":"2003","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025090511531573000_108.4.333.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83387-6"},{"key":"2025090511531573000_108.4.333.33","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-3501"},{"key":"2025090511531573000_108.4.333.34","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-2131"},{"key":"2025090511531573000_108.4.333.35","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1651-2227.1995.tb13792.x","article-title":"Porcine surfactant replacement therapy in newborns of 25-31 weeks' gestation: a randomized, multicentre trial of prophylaxis versus rescue with multiple low doses. The French Collaborative multicentre study Group","volume":"84","author":"Walti","year":"1995","journal-title":"Acta Paediatr"},{"key":"2025090511531573000_108.4.333.36","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2014-306802"},{"key":"2025090511531573000_108.4.333.37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0911781"},{"key":"2025090511531573000_108.4.333.38","first-page":"412","article-title":"Early neurodevelopmental outcome of premature infants in a randomized trial comparing preventilatory and postventilatory surfactant therapy for respiratory distress syndrome","volume":"28","author":"CE","year":"1990","journal-title":"Ann Neurol"},{"key":"2025090511531573000_108.4.333.39","article-title":"Early neurodevelopmental outcome of premature-infants in a ransomized trial comparing prophylactic and rescue surfactant therapy","volume":"29","author":"CE","year":"1991","journal-title":"Pediatric Research"},{"key":"2025090511531573000_108.4.333.40","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-0898"},{"key":"2025090511531573000_108.4.333.41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jpeds.2016.05.070","article-title":"Growth outcomes of preterm infants exposed to different oxygen saturation target ranges from birth","volume":"176","author":"Navarrete","year":"2016","journal-title":"J Pediatr"},{"key":"2025090511531573000_108.4.333.42","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0496(199803)25:3<182::AID-PPUL8>3.0.CO;2-O"},{"key":"2025090511531573000_108.4.333.43","doi-asserted-by":"crossref","DOI":"10.1542\/peds.101.5.e11","article-title":"School-Age follow-up of prophylactic versus rescue surfactant trial: pulmonary, neurodevelopmental, and educational outcomes","volume":"101","author":"Sinkin","year":"1998","journal-title":"Pediatrics"},{"key":"2025090511531573000_108.4.333.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2014.02.054"},{"key":"2025090511531573000_108.4.333.45","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83505-X"},{"key":"2025090511531573000_108.4.333.46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208506"},{"key":"2025090511531573000_108.4.333.47","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jpeds.2018.04.073","article-title":"Extreme preterm infant rates of overweight and obesity at school age in the support neuroimaging and neurodevelopmental outcomes cohort","volume":"200","author":"Vohr","year":"2018","journal-title":"J Pediatr"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2022-324184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T19:05:19Z","timestamp":1757099119000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/archdischild-2022-324184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,6,19]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1136\/archdischild-2022-324184"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2022-324184","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]}}}